CXCR4 and neoplasm: Notably, the presence of CXCR4 has been linked to unfavorable outcomes in multiple different tumor entities, including hematologic malignancies, breast cancer, renal cell carcinoma, gynecologic malignancies, pancreatic adenocarcinoma, and hepatocellular carcinoma (3).